Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENADRYL | McNeil Pharmaceutical | N-005845 DISCN | 1982-01-01 | 3 products |
BENADRYL | McNeil Pharmaceutical | N-006146 DISCN | 1982-01-01 | 2 products, RLD |
BENADRYL PRESERVATIVE FREE | McNeil Pharmaceutical | N-009486 DISCN | 1982-01-01 | 1 products, RLD |
BENYLIN | Pfizer | N-006514 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
24 / 7 life extra strength pain reliever pm | C200263 | 2024-10-30 |
24/7 life allergy relief | C200263 | 2024-12-30 |
acetadryl | OTC monograph not final | 2013-11-12 |
acetaflu nighttime | OTC monograph final | 2020-03-26 |
acetaflu nighttime effervescent | OTC monograph final | 2020-03-26 |
acetamax pm | OTC monograph not final | 2020-08-31 |
acetaminophen 500mg diphenhydramine hcl 25mg | OTC monograph not final | 2020-11-16 |
acetaminophen and diphenhydramine hcl | C200263 | 2024-12-16 |
acetaminophen and diphenhydramine hydrochloride | C200263 | 2025-07-02 |
acetaminophen diphenhydramine hcl | C200263 | 2024-12-19 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 26 | 28 | 95 | 108 | 64 | 315 |
Healthy volunteers/patients | — | — | — | 105 | 2 | 1 | 4 | 20 | 131 |
Essential hypertension | D000075222 | — | I10 | 4 | 4 | 21 | 14 | 7 | 50 |
Infections | D007239 | EFO_0000544 | — | 3 | 9 | 12 | 13 | 11 | 45 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 5 | 9 | 15 | 7 | 38 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 4 | 8 | 12 | 13 | 4 | 38 |
Covid-19 | D000086382 | — | U07.1 | 5 | 14 | 9 | 3 | 2 | 29 |
Syndrome | D013577 | — | — | 2 | 10 | 5 | 7 | 6 | 29 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 2 | 6 | 5 | 13 | 4 | 28 |
Cough | D003371 | — | R05 | 4 | 5 | 6 | 5 | 8 | 28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 14 | 14 | 2 | — | 3 | 32 |
Lymphoma | D008223 | — | C85.9 | 12 | 16 | 2 | — | 1 | 29 |
Leukemia | D007938 | — | C95 | 13 | 12 | 1 | — | 2 | 26 |
Multiple myeloma | D009101 | — | C90.0 | 8 | 13 | 4 | — | 1 | 24 |
Plasma cell neoplasms | D054219 | — | — | 6 | 10 | 4 | — | 1 | 20 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 8 | 11 | 1 | — | 1 | 19 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 8 | 2 | — | 3 | 16 |
Non-small-cell lung carcinoma | D002289 | — | — | 5 | 5 | 5 | — | 1 | 15 |
Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 8 | 1 | 5 | — | — | 14 |
Lung neoplasms | D008175 | — | C34.90 | 4 | 7 | 2 | — | 1 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 8 | 7 | — | — | 1 | 15 |
B-cell lymphoma | D016393 | — | — | 7 | 4 | — | — | — | 11 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 4 | 5 | — | — | 1 | 10 |
Myeloid leukemia acute | D015470 | — | C92.0 | 6 | 4 | — | — | — | 9 |
Hematologic neoplasms | D019337 | — | — | 2 | 6 | — | — | 1 | 9 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 6 | 3 | — | — | — | 9 |
Hodgkin disease | D006689 | — | C81 | 6 | 4 | — | — | — | 9 |
Neuralgia | D009437 | EFO_0009430 | — | — | 8 | — | — | 1 | 9 |
Fibrosis | D005355 | — | — | 3 | 7 | — | — | — | 8 |
Lymphoid leukemia | D007945 | — | C91 | 5 | 2 | — | — | 1 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug interactions | D004347 | — | — | 12 | — | — | — | 3 | 15 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 2 | — | — | — | 3 | 5 |
Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | 3 | — | — | — | 1 | 4 |
Chronic pain | D059350 | — | — | 1 | — | — | — | 3 | 4 |
Pure autonomic failure | D054970 | — | — | 3 | — | — | — | — | 3 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | — | — | — | 1 | 2 |
Peripheral arterial disease | D058729 | EFO_0004265 | — | 1 | — | — | — | 1 | 2 |
Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 2 | — | — | — | — | 2 |
Food-drug interactions | D018565 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Parasomnias | D020447 | — | G47.5 | — | — | — | — | 4 | 4 |
Dyssomnias | D020920 | — | — | — | — | — | — | 3 | 3 |
Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | — | — | 2 | 2 |
Arteriovenous fistula | D001164 | — | Q27.3 | — | — | — | — | 2 | 2 |
Suicidal ideation | D059020 | EFO_0004320 | R45.851 | — | — | — | — | 2 | 2 |
Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 2 | 2 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | — | — | — | 2 | 2 |
Whooping cough | D014917 | EFO_0000650 | A37 | — | — | — | — | 2 | 2 |
Diarrhea | D003967 | — | R19.7 | — | — | — | — | 2 | 2 |
Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | — | — | 1 | 1 |
Drug common name | Diphenhydramine |
INN | diphenhydramine |
Description | Diphenhydramine is an ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. It has a role as a H1-receptor antagonist, an antiemetic, a sedative, an anti-allergic agent, a muscarinic antagonist, an antiparkinson drug, an antipruritic drug, a local anaesthetic, an antidyskinesia agent, an antitussive and a oneirogen. It is an ether and a tertiary amino compound. |
Classification | Small molecule |
Drug class | first-generation antihistamine (ethanolamine), anticholinergic, hallucinogen (deliriant) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN(C)CCOC(c1ccccc1)c1ccccc1 |
PDB | — |
CAS-ID | 58-73-1 |
RxCUI | — |
ChEMBL ID | CHEMBL657 |
ChEBI ID | 4636 |
PubChem CID | 3100 |
DrugBank | DB01075 |
UNII ID | 8GTS82S83M (ChemIDplus, GSRS) |